- Cancer Care Team
Cancer Care Team
To deliver optimal patient outcomesProducts and Services
Cancer Type
Supplies & Tools
Scientific Focus
- Biopharma Partners
- Patients
- Education & Events
- Login
- Contact Us
Products and Services
Cancer Type
Supplies & Tools
Scientific Focus
HER2 is a known negative predictive biomarker in colorectal cancer (CRC). Recent trials have established HER2 as a therapeutic target in CRC. This assay assists in determining eligibility for HER2 therapy in patients with CRC.
Testing will be delayed if the pathology report is not received. Fixation time and fixative used must be indicated on the test requisition form.
Use of fixatives other than 10% formalin may not yield reliable results.
Immunohistochemistry (IHC)
Information on collection, storage, and volume
Formalin fixed paraffin-embedded (FFPE) tissue block or slides
One paraffin block or seven unstained, positively charged tissue slides cut at 4-5 microns
Five unstained slides
Paraffin block transport pouch or slide mailer
Maintain specimen at room temperature.
Tumor type other than colorectal cancer (CRC); fixative other than neutral buffered formalin; insufficient tumor cellularity
Specimen should be fixed in a 10% neutral-buffered formalin. Cold ischemic time should be less than one hour and fixation time should be between six and 72 hours.
Find more tests related to this one.